Indefinite Delivery Contract SPE2DU25D9780

The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) with a ceiling value of $4,999,999.00, awarded by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valid through December 2036, covers the procurement of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. This includes branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. The contract enables the DLA to issue firm fixed-price delivery orders for these pharmaceutical items to support the medical supply needs of Department of Defense (DoD) healthcare sites globally, both for normal day-to-day operations and planned/unplanned contingencies.

The IDC is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which aims to establish multiple regional prime vendor contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The procurement is being conducted as an unrestricted, fully competitive acquisition, with the intent to make at least three different contractor awards across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet regions to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters.